Skip to main content
SMFM 2026 Pregnancy Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Additional registration fee required
Additional registration fee required
Faculty have requested this content not be shared outside of the session
Faculty have requested this content not be shared outside of the session
CME Credit Offered
CME Credit Offered
Abstract Award
Abstract Award
Recording available 2/16-5/2
Recording available 2/16-5/2
AIUM Credit
AIUM Credit
Foundation Awardee
Foundation Awardee
Poster Icons
Abstract Award
Abstract Award
Foundation Awardee
Foundation Awardee

Luncheon Roundtables

Decoding the Fetus: Strategies to Implement Genome Sequencing in MFM Practice

Wednesday, February 11, 2026
12:00 PM - 1:00 PM  
Location: Summit 227 - 228

Additional registration fee required

    Roundtable Leader(s)

  • Manesha Putra, MD (he/him/his)

    Assistant Professor
    University of Colorado Anschutz Medical Campus
    Aurora, Colorado, United States

    • Roundtable Presenter(s)

  • Caitlin Baptiste, MD

    Assistant Professor of Obstetrics and Gynecology
    Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University Irving Medical Center
    New York, New York, United States

  • RR

    Rebecca Reimers, MD, MPH (she/her/hers)

    Scripps Research Institute, Rady Children's Institute for Genomic Medicine

  • Teresa Sparks, MD, MS (she/her/hers)

    Associate Professor, Maternal-Fetal Medicine and Clinical Genetics
    University of California, San Francisco
    San Francisco, California, United States

This luncheon roundtable, led by experts in prenatal genetics, will provide practical, actionable strategies for integrating whole-genome sequencing (WGS) and whole-exome sequencing (WES) into maternal–fetal medicine (MFM) practice. Aimed at clinicians navigating the expanding role of genomic testing in pregnancy, the session will: 1) review the latest advances and evidence in prenatal WGS/WES; 2) outline clinical indications and decision-making pathways for when to offer testing; 3) detail best practices for pre-test and post-test counseling; 4) demystify result interpretation and dissect the anatomy of a genomic report (including variant classification, incidental findings, and limitations); and 5) share practical strategies to optimize insurance authorization and reimbursement.